Clinical trial Recruiting at 1 site Interventional

Evaluating biomarkers for the outcome of pulpotomy in molars with irreversible pulpitis

Official title: Discovering Prognostic Biomarkers for Pulpotomy Outcome in Permanent Mature Teeth With Irreversible Pulpitis

Run by The University of Hong Kong · NCT06514053 · Data updated 2026-11-12

This study is testing whether a full pulpotomy can work better than root canal treatment for molars with irreversible pulpitis by looking at inflammation markers and checking how well the treatments perform over time.

More Pulpitis - Irreversible trials

Quick facts

Study typeInterventional
SexAll
Enrollment192 (estimated)
SponsorThe University of Hong Kong
Academic / other
Locations1 site (Hong Kong)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedDecember 2025
Study endsDecember 2026
Registry record updatedJuly 23, 2024
Trial IDNCT06514053 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with permanent molars exhibiting clinical signs of irreversible pulpitis and deep carious lesions.

Probably not a fit

Patients with apical radiolucency, non-responsive teeth, or those with compromised immune systems may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to recruit 180 molars diagnosed with irreversible pulpitis to assess the outcomes of full pulpotomy compared to root canal treatment. A total of 120 teeth will undergo pulpotomy, while 60 will receive root canal treatment as a control. Blood samples and pulp tissues will be collected for analysis to profile inflammation-related biomarkers. The treatment outcomes will be evaluated clinically and radiographically at 6 and 12 months post-treatment.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment strategies for irreversible pulpitis, enhancing patient outcomes.

How similar studies have gone: While there may be studies on pulpotomy and root canal treatments, this specific approach focusing on biomarkers is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Permanent molars showing clinical and radiographic evidence of a deep carious lesion (extend to the three-quarters thickness of dentine radiographically) extending close to the pulp chamber
* Clinical diagnosis of irreversible pulpitis, including spontaneous pain, lingering pain with cold stimulation, no or mild tenderness to percussion, normal apical tissue or widening of the periodontal ligament space but with no signs of periapical periodontitis (i.e., PAI score 1 or 2)
* Positive response to cold and electric pulp test.

Exclusion Criteria:

* Tooth with no response to the cold and electric tests, presence of apical radiolucency (greater than periodontal widening), signs of canal calcification and resorption, history of trauma, unrestorable or nonfunctional teeth, and evidence of perio-endo lesion
* Intraoperative bleeding time is more than 10 minutes or less than 10 μL pulpal blood can be obtained
* Patients with a compromised immune status (such as HIV or organ transplant) or with any history of taking analgesics/antibiotics in the past one week.

Where it's running

  • Clinical Research Centre, Faculty of Dentistry, The University of Hong Kong
    Hong Kong, Hong Kong
    Recruiting

Study contacts

  • Principal investigator: Chengfei Zhang — The University of Hong Kong
  • Study coordinator: Rong Cen
  • Email: cenrong@hku.hk
  • Phone: +852 28590290

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.